What are the characteristics that lead physicians to perceive an ICU stay as non-beneficial for the patient?


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 24 04 2019
accepted: 20 08 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 11 3 2020
Statut: epublish

Résumé

We sought to describe the characteristics that lead physicians to perceive a stay in the intensive care unit (ICU) as being non-beneficial for the patient. In the first step, we used a multidisciplinary focus group to define the characteristics that lead physicians to consider a stay in the ICU as non-beneficial for the patient. In the second step, we assessed the proportion of admissions that would be perceived by the ICU physicians as non-beneficial for the patient according to our focus group's definition, in a large population of ICU admissions in 4 French ICUs over a period of 4 months. Among 1075 patients admitted to participating ICUs during the study period, 155 stays were considered non-beneficial for the patient, yielding a frequency of 14.4% [95% confidence interval (CI) 8.9, 19.9]. Average age of these patients was 72 ±12.8 years. Mortality was 43.2% in-ICU [95%CI 35.4, 51.0], 55% [95%CI 47.2, 62.8] in-hospital. The criteria retained by the focus group to define a non-beneficial ICU stay were: patient refusal of ICU care (23.2% [95%CI 16.5, 29.8]), and referring physician's desire not to have the patient admitted (11.6% [95%CI 6.6, 16.6]). The characteristics that led physicians to perceive the stay as non-beneficial were: patient's age (36.8% [95%CI 29.2, 44.4]), unlikelihood of recovering autonomy (61.9% [95%CI 54.3, 69.6]), prior poor quality of life (60% [95%CI 52.3, 67.7]), terminal status of chronic disease (56.1% [95%CI 48.3, 63.9]), and all therapeutic options have been exhausted (35.5% [95%CI 27.9, 43.0]). Factors that explained admission to the ICU of patients whose stay was subsequently judged to be non-beneficial included: lack of knowledge of patient's wishes (52% [95%CI 44.1, 59.9]); decisional incapacity (sedation) (69.7% [95%CI 62.5, 76.9]); inability to contact family (34% [95%CI 26.5, 41.5]); pressure to admit (from family or other physicians) (50.3% [95%CI 42.4, 58.2]). Non-beneficial ICU stays are frequent. ICU admissions need to be anticipated, so that patients who would yield greater benefit from other care pathways can be correctly oriented in a timely manner.

Identifiants

pubmed: 31490986
doi: 10.1371/journal.pone.0222039
pii: PONE-D-19-11673
pmc: PMC6730882
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0222039

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2000 Mar 15;283(11):1437-44
pubmed: 10732933
Crit Care Med. 2001 Feb;29(2 Suppl):N46-51
pubmed: 11228573
Crit Care Med. 2001 Nov;29(11):2132-6
pubmed: 11700409
JAMA. 2003 Sep 3;290(9):1166-72
pubmed: 12952998
Intensive Care Med. 2004 Feb;30(2):325-330
pubmed: 14647888
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Anaesth Intensive Care. 2011 Jul;39(4):650-8
pubmed: 21823385
JAMA. 2011 Oct 5;306(13):1483-4
pubmed: 21972312
Patient Educ Couns. 2012 Jun;87(3):277-88
pubmed: 22115975
JAMA. 2011 Dec 28;306(24):2694-703
pubmed: 22203538
Intensive Care Med. 2012 May;38(5):830-7
pubmed: 22398756
Crit Care. 2013 Apr 26;17(2):224
pubmed: 23672813
JAMA Intern Med. 2013 Nov 11;173(20):1887-94
pubmed: 24018712
Am J Respir Crit Care Med. 2014 Oct 15;190(8):855-66
pubmed: 25162767
Crit Care Med. 2015 May;43(5):1102-11
pubmed: 25574794
Intensive Care Med. 2015 Oct;41(10):1844-6
pubmed: 26215678
Intensive Care Med. 2015 Oct;41(10):1838-40
pubmed: 26215681
Med Klin Intensivmed Notfmed. 2016 May;111(4):310-6
pubmed: 26337761
J Crit Care. 2016 Aug;34:125-30
pubmed: 27288625
Crit Care Med. 2016 Aug;44(8):1553-602
pubmed: 27428118
Ann Transl Med. 2016 Aug;4(16):316
pubmed: 27668236
Anaesth Crit Care Pain Med. 2018 Apr;37(2):113-119
pubmed: 28826983
Ann Transl Med. 2017 Dec;5(Suppl 4):S38
pubmed: 29302594
Ann Transl Med. 2017 Dec;5(Suppl 4):S46
pubmed: 29302602
Ann Transl Med. 2017 Dec;5(Suppl 4):S47
pubmed: 29302603
Intensive Care Med. 2018 Jul;44(7):1039-1049
pubmed: 29808345
PLoS One. 2018 Oct 18;13(10):e0205689
pubmed: 30335804
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Crit Care Med. 1981 Aug;9(8):591-7
pubmed: 7261642
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858

Auteurs

Jean-Pierre Quenot (JP)

Department of Intensive Care, François Mitterrand, University Hospital, Dijon, France.
Lipness Team, INSERM Research Centre LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France.
INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.

Audrey Large (A)

Department of Intensive Care, François Mitterrand, University Hospital, Dijon, France.

Nicolas Meunier-Beillard (N)

INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.
DRCI, USMR, Francois Mitterrand University Hospital, Dijon, France.

Paul-Simon Pugliesi (PS)

Department of Intensive Care, William Morey Hospital, Chalon sur Saône, France.

Pamina Rollet (P)

Department of Intensive Care, Nord Franche-Comté Hospital, Trevenans, France.

Amaury Toitot (A)

Department of Intensive Care, Nord Franche-Comté Hospital, Trevenans, France.

Pascal Andreu (P)

Department of Intensive Care, François Mitterrand, University Hospital, Dijon, France.

Hervé Devilliers (H)

INSERM CIC 1432, Clinical Epidemiology, University of Burgundy, Dijon, France.
Department of Internal Medicine, François Mitterrand University Hospital, Dijon, France.

Antoine Marchalot (A)

Department of Intensive Care, Dieppe General Hospital, Dieppe, France.

Fiona Ecarnot (F)

EA3920, Department of Cardiology, University Hospital Besancon, France.

Auguste Dargent (A)

Department of Intensive Care, François Mitterrand, University Hospital, Dijon, France.
Lipness Team, INSERM Research Centre LNC-UMR1231 and LabEx LipSTIC, University of Burgundy, Dijon, France.

Jean-Philippe Rigaud (JP)

Department of Intensive Care, Dieppe General Hospital, Dieppe, France.
Espace de Réflexion Ethique de Normandie, University Hospital Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH